At Thanksgiving I was able to talk with one of my nephews that is a manager at a plastics company. They are laying off because some of their customers are using less plastic because they are selling less junk food.
GLP-1 really are making an impact!
Also
Stockholm, Sweden, June 23, 2025 – Atrogi AB, a clinical-stage biotechnology company pioneering muscle-targeted therapies, today announces the publication of a landmark study in the prestigious scientific journal Cell, titled “GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity.” This paper highlights Atrogi’s first-in-class oral β2-adrenergic receptor agonist, ATR-258, which precisely activates skeletal muscle metabolism through novel GRK2-biased signaling. This transformative approach enhances glucose uptake and improves body composition by reducing fat and preserving lean muscle without the cardiovascular risks typically associated with β2-agonists.
One of the bad problems with GLP-1 s is that the mimic starvation and this causes muscle mass loss. This drug if it passes through all three stages of studies would enhance muscle mass.
Cheers
Qazulight